prospective double-blinded randomized control trial
Conditions
Interventions
Patients belonging to Group C (control group) received total volume of 10ml contain 4 ml of 4% lidocaine (160 mg of lidocaine)+ normal saline
Patients belonging to Group E (expermental group) receive
Sponsors
faculty of medicine - menoufia university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA class I, II or III undergoing diagnostic procedures such as broncho-alveolar lavage, endobronchial or transbronchial biopsies, or brush cytology were permitted
Exclusion criteria
Exclusion criteria: , we will not include patients requiring cryobiopsy or endobronchial ultrasound because these procedures are performed under deep sedation including fiberoptic intubation in our institution Patients on opioid therapy, central nervous system depressants, or with hepatic or renal disease, pregnancy or lactation, psychiatric disorder, and/or bleeding disorder are not included. We also excluded patients established respiratory depression; sleep apnea, a history of hypersensitivity to one of the drugs and/or not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Patient discomfort to bronchoscopy | — |
Countries
Africa
Contacts
Public Contactnoha afify
faculty of medicine menoufia university department of anesthesia
Outcome results
None listed